Patent · US Active

Compositions and methods of treating cancer

US9801922B2 · kind B2 · utility

14Cited by
0References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 2, 2012
Grant dateOct 31, 2017
Priority date
Expiry dateJun 22, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods to treat cancer with an agent that increases reactive oxygen species (ROS) levels in cancer cell mitochondria (“an XTPP agent”) or a pharmaceutically acceptable salt thereof, an inhibitor of hydroperoxide metabolism and a pharmaceutically acceptable diluent or carrier.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.